Cancer drug trial offers hope for HIV 'Cure' - could end daily pills
NCT ID NCT07145164
Summary
This study is testing whether a cancer drug called N-803 (also known as IL-15) can help people with HIV control the virus without needing daily medication. Researchers want to see if stimulating the immune system can change how HIV hides in the body, potentially allowing people to stop their regular HIV drugs temporarily. The study involves 20 participants who will carefully stop their HIV medication under medical supervision to test this approach.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UCSF
San Francisco, California, 94044, United States
Conditions
Explore the condition pages connected to this study.